Camlin Fine Sciences · NSE: CAMLINFINE · BSE: 532834
Q4 FY21 results · Jan–Mar 2021
Camlin Fine Sciences reported revenue from operations of ₹326.62 crore (up 11.5% from Q4 FY20) and net profit of ₹15.72 crore (up 666.7% from Q4 FY20) for Q4 FY21 (Jan–Mar 2021), on a consolidated basis.
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 326.62 | 292.87 | +11.5% | 297.92 | +9.6% |
| Other income | 2.09 | 2.77 | −24.6% | 1.14 | +83.1% |
| Total income | 328.72 | 295.64 | +11.2% | 299.07 | +9.9% |
| Profit before tax | 28.60 | 12.71 | +125.1% | 27.81 | +2.9% |
| Net profit for the period | 15.72 | 2.05 | +666.7% | 19.42 | −19.1% |
| Attributable to shareholders of the company | 14.27 | 2.67 | +433.9% | 15.42 | −7.5% |
| EPS, basic (₹) | 1.16 | 0.22 | +427.3% | 1.26 | −7.9% |
| Net margin (%) | 4.8 | 0.7 | 6.5 |
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 168.46 | 139.54 | +20.7% | 163.64 | +2.9% |
| Other income | 2.78 | 15.71 | −82.3% | 1.42 | +96.6% |
| Total income | 171.24 | 155.25 | +10.3% | 165.06 | +3.7% |
| Profit before tax | 5.90 | 19.78 | −70.2% | 4.90 | +20.5% |
| Net profit for the period | 2.14 | 16.54 | −87.1% | 3.36 | −36.4% |
| EPS, basic (₹) | 0.17 | 1.36 | −87.5% | 0.27 | −37.0% |
| Net margin (%) | 1.3 | 11.9 | 2.1 |
Consolidated
- Filed with BSE
- 29 May 2021, 19:55 IST
- Board meeting
- 28 May 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 29 May 2021, 19:55 IST
- Board meeting
- 28 May 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Audited
- Source
- XBRL filing on BSE